Stock & Company Details
Innoviva Inc $INVA
Price:
46,691,331
74M
$1.6B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
6.39
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
INVA technical indicators
Latest Innoviva Inc (INVA) technical indicators as of 2026-07-27: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
40.75 3.5%
MACD:
-0.33 3.1%
SMA 50:
$22.23 0.2%
SMA 200:
$21.43 0.1%
EMA 20:
$21.87 0.3%
Bollinger Bands:
22.94 / 20.95
Stochastic:
15.67 1.5%
ADX 14:
16.95 0.9%
ATR 14:
0.55 0.6%
CCI 20:
-93.19 14.2%
OBV:
26.31M 2.3%
ROC 12:
-4.05% 8.1%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.
Finance Bot
Ask your questions
Start by typing a question below.
